Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advantan Maintenance in Atopic Dermatitis
NCT00185510Phase 4Completed
- Sponsor
- LEO Pharma
- Start
- Mar 2005
- Primary completion
- May 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Advantan Maintenance with Placebo Maintenance (2 arms). Primary endpoint: Time to relapse in the maintenance phase at 16 weeks. Started Mar 2005; status: completed.
02
Drugs
methylprednisolone aceponate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00185510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185510.